ACST Stock

The news is bad for Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSX:ACST), according to Ec... Read More

Delays at Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSXV:ACST) have Echelon Wealth Partn... Read More

Disappointing results for its lead product candidate CaPre have led Mackie research capital analyst ... Read More

Quebec-based omega-3 drug developer Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSXV:ACST)... Read More

Biopharm company Acasti Pharma (Acasti Pharma Stock Quote, Chart, News NASDAQ:ACST) has a boatload o... Read More

Does Acasti Pharma still have upside? Echelon Wealth Partners analyst Douglas Loe could be forgiven ... Read More

With its best-in-class omega-3 drug CaPre currently in Phase III trials, Acasti Pharma (Acasti Pharm... Read More

Echelon Wealth Partners analyst Douglas Loe is staying put on drug developer Acasti Pharma (Acasti P... Read More

Acasti Pharma’s (Acasti Pharma Stock Quote, Chart TSXV:ACST) third quarter results are in, but the... Read More

Results from a recent study of an omega-3 drug used to treat cardiovascular disease should increase ... Read More

Following pharmaceutical company Amarin’s positive cardiovascular results for its omega-3 fish oil... Read More

With what he describes as a “best in class” Omega-3 drug in development, Mackie Research... Read More

Acasti Pharma’s (Acasti Pharma Stock Quote, Chart, News: TSXV:ACST) downstream economics look appe... Read More

All eyes will be on upcoming Phase III drug trials for Acasti Pharma’s (TSXV:ACST) cardiovascular ... Read More